Mirae Asset Global Investments’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-63,547
Closed -$1.09M 2169
2024
Q1
$1.09M Hold
63,547
﹤0.01% 1492
2023
Q4
$1.03M Hold
63,547
﹤0.01% 1606
2023
Q3
$782K Hold
63,547
﹤0.01% 1660
2023
Q2
$1.02M Hold
63,547
﹤0.01% 1554
2023
Q1
$1.11M Hold
63,547
﹤0.01% 1494
2022
Q4
$587K Hold
63,547
﹤0.01% 1798
2022
Q3
$547K Buy
63,547
+31,469
+98% +$313K ﹤0.01% 1819
2022
Q2
$261K Buy
+32,078
New +$306K ﹤0.01% 2052
2021
Q2
Sell
-716,547
Closed -$34.6M 1724
2021
Q1
$34.6M Buy
716,547
+207,938
+41% +$10.8M 0.12% 227
2020
Q4
$27.4M Buy
508,609
+200,749
+65% +$9.07M 0.1% 242
2020
Q3
$11.4M Buy
+307,860
New +$11.4M 0.06% 350

Other funds holding NEO

Mirae Asset Global Investments's NEO Position: Q2 2024 in Review

Mirae Asset Global Investments sold out of NeoGenomics (NEO) in Q2 2024, closing a stake of 63,547 shares — an estimated $1.09M sold.

Mirae Asset Global Investments first reported a position in NEO in Q3 2020 and held it in 11 quarters. The position peaked at $34.6M in Q1 2021. 259 funds tracked by Wall St. Rank hold NEO as of Q2 2024.

  • Mirae Asset Global Investments reported no remaining NeoGenomics position as of Q2 2024 after selling out during the quarter.
  • Mirae Asset Global Investments sold 63,547 NeoGenomics shares in Q2 2024, an estimated $1.09M.
  • Mirae Asset Global Investments first reported a position in NeoGenomics in Q3 2020 and held it in 11 quarters.
  • Mirae Asset Global Investments's NeoGenomics position peaked at $34.6M in Q1 2021.
  • 259 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2024.

Based on Mirae Asset Global Investments's 13F filing for Q2 2024, filed 30 Jul 2024.